Grab your favorite coffee. This is where you’ll find all the substance you require, and more.

Cognivia-Narrow-Hero-1
Insights

Embracing Human Complexity in Clinical Research

As clinical trials become more diverse, patient heterogeneity, placebo responses, and inter-site variability become more pronounced, contributing to high rates of failed trials and extended development timelines…

Read More
Insights

Capturing Patients Diversity as the Next Challenge in Drug Development? Insights from IASP 2024 

Earlier this month, the IASP (International Association for the Study of Pain) meeting marked a significant moment in honoring the vision of Professor John Bonica founder of…

Read More
Insights

How Cognivia Turns Traits Into Data with a Validated Questionnaire & Machine Learning

Learn more about the development of the MPsQ and the its use as part of the Placebell©™ technology.

Read More
Insights

Pain: the Tree that Hides the Forest of Symptoms

The 2024 International Osteoarthritis Research Society (OARSI) conference concluded last week, offering valuable exchange and information. What insights could we gather from these dynamic four days? One…

Read More
Insights

Global Reach, Local Understanding: Cognivia’s Participant Questionnaire Validated in Over 50 Languages for Comprehensive Clinical Trials 

For high quality clinical trial data, the voice of the participant (i.e. patient and/or caregiver) must be captured in the language that they can understand. In this…

Read More
Insights

Expectations of Improvement in Clinical Trials: site or patient related?

There are multiple techniques to account for these expectations in studies, including site stafftraining, subject training before the start of the study, and applying  an adjustment covariate.

Read More

Understand patient differences in your next clinical trial

Increase your trial’s success rates and bring new therapies to patients faster.

Tell us about your clinical trial below, and our team will be in touch.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.